Trial intelligence / Profile preview

Salsalate for vascular and autonomic dysfunction in obese prediabetes

NCT01977417Phase 2Terminated

Start
Nov 2012
Primary completion
Apr 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Amigesic in prediabetes, obesity. Started Nov 2012; status: terminated.

02

Drugs

Amigesic
03

Conditions

prediabetesobesity

Beyond the preview

Go deeper on NCT01977417.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01977417.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call